It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Amneal Pharmaceuticals Inc (AMRX) shows that investor sentiment remained same, with the stock’s consolidated last price to $4.29. The Amneal Pharmaceuticals Inc has recorded 16,831 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Amneal to Participate at Upcoming Investor Conferences.
Amneal Pharmaceuticals Inc is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $4.29 and fluctuated between $4.3500 as its day high and $4.1700 as its day low. The current market capitalization of Amneal Pharmaceuticals Inc is $661.48M. A total of 1.53 million shares were traded on the day, compared to an average of 1.31M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, AMRX has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 29,302 shares. Over the last 12 months, there were 22 BUYs and 12 SELLs from insiders. Insiders purchased 1,170,138 shares during that period but sold 4,053,721.
In the most recent transaction, BOYER ANDREW S sold 29,302 shares of AMRX for 4.13 per share on Aug 11. After the transaction, the Executive Vice President now owns 244,739 company shares. In a previous transaction on Dec 12, TPG GP A, LLC sold 3,884,600 shares at 2.34 per share. AMRX shares that Former 10% Owner owns now total 12,328,767.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for AMRX in the last 3 months, the mean price target is $5.25 with high estimates of $6.00 and low estimates of $5.00. In terms of 52-week highs and lows, AMRX has a high of $4.74 and a low of $1.24.
As of this writing, AMRX has an earnings estimate of $0.11 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $0.14 per share and a lower estimate of $0.09. The company reported an EPS of $0.12 in the last quarter, which was 20.00% higher than expectations of $0.1.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AMRX’s latest balance sheet shows that the firm has $247.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.88B in debt and $677.24M in liabilities at the time. Its Book Value Per Share was $2.07, while its Total Shareholder’s Equity was $366.97M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRX is Buy with a score of 4.20.